These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 15379728)
1. Macrolide resistance in Streptococcus pneumoniae: clonality and mechanisms of resistance in 24 countries. Bozdogan B; Bogdanovich T; Kosowska K; Jacobs MR; Appelbaum PC Curr Drug Targets Infect Disord; 2004 Sep; 4(3):169-76. PubMed ID: 15379728 [TBL] [Abstract][Full Text] [Related]
2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477 [TBL] [Abstract][Full Text] [Related]
3. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones. Ikenaga M; Kosowska-Shick K; Gotoh K; Hidaka H; Koga H; Masunaga K; Nagai K; Tsumura N; Appelbaum PC; Matsuishi T Diagn Microbiol Infect Dis; 2008 Sep; 62(1):16-22. PubMed ID: 18068325 [TBL] [Abstract][Full Text] [Related]
4. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France. Marchandin H; Jean-Pierre H; Jumas-Bilak E; Isson L; Drouillard B; Darbas H; Carrière C Pathol Biol (Paris); 2001 Sep; 49(7):522-7. PubMed ID: 11642013 [TBL] [Abstract][Full Text] [Related]
6. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008. Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG; J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485 [TBL] [Abstract][Full Text] [Related]
7. Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece. Grivea IN; Sourla A; Ntokou E; Chryssanthopoulou DC; Tsantouli AG; Syrogiannopoulos GA BMC Infect Dis; 2012 Oct; 12():255. PubMed ID: 23057516 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. Farrell DJ; Morrissey I; Bakker S; Felmingham D J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227 [TBL] [Abstract][Full Text] [Related]
9. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Wolter N; von Gottberg A; du Plessis M; de Gouveia L; Klugman KP; Int J Antimicrob Agents; 2008 Jul; 32(1):62-7. PubMed ID: 18339522 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Reinert RR; Reinert S; van der Linden M; Cil MY; Al-Lahham A; Appelbaum P Antimicrob Agents Chemother; 2005 Jul; 49(7):2903-13. PubMed ID: 15980367 [TBL] [Abstract][Full Text] [Related]
11. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK; J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of serotypes and molecular epidemiology of Streptococcus pneumoniae strains isolated from children in Beijing, China: identification of two novel multiply-resistant clones. McGee L; Wang H; Wasas A; Huebner R; Chen M; Klugman KP Microb Drug Resist; 2001; 7(1):55-63. PubMed ID: 11310804 [TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway. Littauer P; Sangvik M; Caugant DA; Høiby EA; Simonsen GS; Sundsfjord A; J Clin Microbiol; 2005 May; 43(5):2125-32. PubMed ID: 15872231 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene. Dobay O; Rozgonyi F; Amyes SG Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263 [TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997-2017. Kastrin T; Paragi M; Erčulj V; Žohar Čretnik T; ; Bajec T; Čižman M J Glob Antimicrob Resist; 2019 Mar; 16():242-248. PubMed ID: 30391398 [TBL] [Abstract][Full Text] [Related]
16. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. Walsh F; Willcock J; Amyes S J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study. Brown SD; Farrell DJ; Morrissey I J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684 [TBL] [Abstract][Full Text] [Related]
19. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002. Farrell DJ; Jenkins SG J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832 [TBL] [Abstract][Full Text] [Related]